NCT00843102 Investigation of Coronary and Pulmonary Circulatory Parameters in Systemic Sclerosis Status COMPLETED Phase N/A
NCT00775463 Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine Status COMPLETED Phase PHASE2
NCT00707187 Trial of IC351 in Female Scleroderma Patients With Raynaud's and Sexual Dysfunction Status COMPLETED Phase PHASE2
NCT00706082 Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) Status TERMINATED Phase N/A
NCT00704665 Recombinant Human Relaxin in the Treatment of Diffuse Scleroderma Status COMPLETED Phase PHASE3
NCT00684255 Reduced Intensity Transplant in Medically Refractory Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc) Status TERMINATED Phase PHASE1
NCT00668473 Angiogenic/Angiostatic Mediators in Patients With Systemic Sclerosis Status COMPLETED Phase N/A
NCT00667134 Stimulatory Autoantibodies to the Platelet-Derived Growth Factor Receptor (PDGFR) in Patients With Systemic Sclerosis Status COMPLETED Phase N/A
NCT00628797 Effectiveness of UVA1-irradiation in the Treatment of Early Skin Fibrosis in Patients Suffering From Systemic Sclerosis Status TERMINATED Phase PHASE1/PHASE2
NCT00622687 Effect of Different Iloprost Doses on Symptoms in Systemic Sclerosis Status TERMINATED Phase PHASE2
NCT00555581 Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis Status COMPLETED Phase PHASE2
NCT00512902 A Study Using The Experimental Drug Called Imatinib (Gleevec) in Subjects With Systemic Sclerosis Status COMPLETED Phase PHASE1/PHASE2
NCT00453752 Non-Invasive Diagnostic and Functional Evaluation of Cardiac Involvement in Patients With Systemic Sclerosis Status UNKNOWN Phase N/A
NCT00377949 Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients Status COMPLETED Phase N/A
NCT00213460 Small Bowel Motor Impairment in Scleroderma: Results of a Prospective 5-year Manometric Follow-up Status COMPLETED Phase N/A